RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ScreeningValuable perspective priceless.
I'm getting very impatient after 11 years and Don's incompetence and dishonesty strikes me as the last failings of a man clearly in the midst of the Peter principle of failure.
I hope you are right.
It all depends on the controller's objectives. I would assume that Hepa's control of China and the regions could lead them to both cash flow and capital gain objectives. I'm also assuming that ORI Capital wants ROI within their expected time frame, perhaps 3 to 6 years? Therefore, they may take action on Don's obvious inability to move the business forward.
Eastern is a bit odd. They sold off their California investment in an Alzheimer's research biotech years ago after hanging in for 10 plus years so the fact they they have held their position in RVX and ZCC (I assume) seems to bode well for the science and, perhaps, a vote of confidence in Dr Wong (as the old relationship between Ken Dart and Dr Wong may be holding). The fact that Eastern has not carried BoM through to the final stage (at least currently) suggests, to me, a clear lack of confidence in Don.
So I do think and hope that Don's days are numbered. This science needs competent financial and business support.
GLTA
Toinv